References
- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53. doi:https://doi.org/10.1002/ijc.31937
- Hassan M, Watari H, Abualmaaty A, Ohba Y, Sakuragi N. Apoptosis and molecular targeting therapy in cancer. BioMed Res Int. 2014;2014:150845.
- Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516. Vol. doi:https://doi.org/10.1080/01926230701320337
- Arruebo M, Vilaboa N, Sáez-Gutierrez B, Lambea J, Tres A, Valladares M, González-Fernández A. Assessment of the evolution of cancer treatment therapies. Cancers (Basel). 2011;3(3):3279–330. doi:https://doi.org/10.3390/cancers3033279
- Sudhakar A. History of cancer, ancient and modern treatment methods. J Cancer Sci Ther. 2009;1(2):1–iv. doi:https://doi.org/10.4172/1948-5956.100000e2
- Desai AG, Qazi GN, Ganju RK, El-Tamer M, Singh J, Saxena AK, Bedi YS, Taneja SC, Bhat HK. Medicinal plants and cancer chemoprevention. Curr Drug Metab. 2008;9(7):581–91. doi:https://doi.org/10.2174/138920008785821657
- Fridlender M, Kapulnik Y, Koltai H. Plant derived substances with anti-cancer activity: from folklore to practice. Front Plant Sci. 2015;6:799. doi:https://doi.org/10.3389/fpls.2015.00799
- Greenwell M, Rahman PKSM. Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res. 2015;6(10):4103–12. http://www.ncbi.nlm.nih.gov/pubmed/26594645. doi:https://doi.org/10.13040/IJPSR.0975-8232.6(10).4103-12
- da Silva MV, de Moura NG, Motoyama AB, Ferreira VM. A review of the potential therapeutic and cosmetic use of propolis in topical formulations. J Appl Pharm Sci. 2020;10(1):131–41.
- Simone-Finstrom M, Spivak M. Propolis and bee health: the natural history and significance of resin use by honey bees. Apidologie. 2010;41(3):295–311. doi:https://doi.org/10.1051/apido/2010016
- Castaldo S, Capasso F. Propolis, an old remedy used in modern medicine. Fitoterapia. 2002;73(Suppl. 1):S1–S6. doi:https://doi.org/10.1016/S0367-326X(02)00185-5
- Wagh VD. Propolis: a wonder bees product and its pharmacological potentials. Adv Pharmacol Sci. 2013;2013:308249. doi:https://doi.org/10.1155/2013/308249
- Akyol S, Ozturk G, Ginis Z, Armutcu F, Yigitoglu MR, Akyol O. In vivo and in vitro antineoplastic actions of Caffeic acid phenethyl ester (CAPE): therapeutic perspectives. Nutr Cancer. 2013;65(4):515–26. doi:https://doi.org/10.1080/01635581.2013.776693
- Sforcin JM. Biological properties and therapeutic applications of propolis. Phytother Res. 2016;30(6):894–905. doi:https://doi.org/10.1002/ptr.5605
- Escriche I, Juan-Borrás M. Standardizing the analysis of phenolic profile in propolis. Food Res Int. 2018;106:834–41. doi:https://doi.org/10.1016/j.foodres.2018.01.055. 29579994
- Devequi-Nunes D, Machado BAS, Barreto GdA, Rebouças Silva J, da Silva DF, da Rocha JLC, Brandão HN, Borges VM, Umsza-Guez MA. Chemical characterization and biological activity of six different extracts of propolis through conventional methods and supercritical extraction. PLoS One. 2018;13(12):e0207676. doi:https://doi.org/10.1371/journal.pone.0207676
- El-Guendouz S, Lyoussi B, Miguel MG. Insight on propolis from mediterranean countries: chemical composition, biological activities and application fields. Chem Biodivers. 2019;16:e1900094. doi:https://doi.org/10.1002/cbdv.201900094
- Premratanachai P, Chanchao C. Review of the anticancer activities of bee products. Asian Pac J Trop Biomed. 2014;4(5):337–44. doi:https://doi.org/10.12980/APJTB.4.2014C1262
- Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci. 2005;38(1):1–7. doi:https://doi.org/10.1016/j.jdermsci.2004.10.011
- Sawicka D, Car H, Borawska MH, Nikliński J. The anticancer activity of propolis. Folia Histochem Cytobiol. 2012;50(1):25–37. doi:https://doi.org/10.5603/FHC.2012.0004
- Vit P, Huq F, Barth O, Campo M, Pérez-Pérez E, Tomás-Barberán F, Santos E. Use of propolis in cancer research. BJMMR. 2015;8(2):88–109. doi:https://doi.org/10.9734/BJMMR/2015/16216
- Aru B, Güzelmeric E, Akgül A, Demirel GY, Kırmızıbekmez H. Antiproliferative activity of chemically characterized propolis from Turkey and its mechanisms of action. Chem Biodivers. 2019;16(7).
- Singh VK, Saini A, Chandra R. The implications and future perspectives of nanomedicine for cancer stem cell targeted therapies. Front Mol Biosci. 2017;4: 52. doi:https://doi.org/10.3389/fmolb.2017.00052
- Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3:7. doi:https://doi.org/10.1038/s41392-017-0004-3
- Aghebati-Maleki A, Dolati S, Ahmadi M, Baghbanzhadeh A, Asadi M, Fotouhi A, Yousefi M, Aghebati-Maleki L. Nanoparticles and cancer therapy: perspectives for application of nanoparticles in the treatment of cancers. J Cell Physiol. 2020;235(3):1962–72. doi:https://doi.org/10.1002/jcp.29126
- Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR. Niosomes: novel sustained release nonionic stable vesicular systems - an overview. Adv Colloid Interface Sci. 2012;183–184:46–54. doi:https://doi.org/10.1016/j.cis.2012.08.002
- Ag Seleci D, Seleci M, Walter JG, Stahl F, Scheper T. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. J Nanomater. 2016;2016:1–13. doi:https://doi.org/10.1155/2016/7372306
- Chen S, Hanning S, Falconer J, Locke M, Wen J. Recent advances in non-ionic surfactant vesicles (niosomes): fabrication, characterization, pharmaceutical and cosmetic applications. Eur J Pharm Biopharm. 2019;144:18–39. doi:https://doi.org/10.1016/j.ejpb.2019.08.015
- Örs G, Gülçe İz S. Cytoprotective effect of a functional antipollutant blend through reducing B[a] P-induced intracellular oxidative stress and UVA exposure. Turk J Biol. 2018;42(5):453–62. doi:https://doi.org/10.3906/biy-1802-43.
- Ge X, Wei M, He S, Yuan WE. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics. 2019;11(2):55. doi:https://doi.org/10.3390/pharmaceutics11020055
- Hasan AA. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride. Pharm Dev Technol. 2014;19(6):748–54. doi:https://doi.org/10.3109/10837450.2013.829095
- Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm. 1994;105(1):1–6. doi:https://doi.org/10.1016/0378-5173(94)90228-3
- Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005;306(1–2):71–82. doi:https://doi.org/10.1016/j.ijpharm.2005.09.023
- Dan N. Core–shell drug carriers: liposomes, polymersomes, and niosomes [Internet]. In: Nanostructures for drug delivery. Amsterdam: Elsevier Inc; 2017. p. 63–105. https://doi.org/10.1016/B978-0-323-46143-6/00002-6.
- Leary E, Curran S, Susienka M, Manning KL, Blakely AM, Morgan JR. Micro-moulded non-adhesive hydrogels to form multicellular microtissues - the 3D Petri Dish®. In: Technology platforms for 3D cell culture. Wiley; 2017.
- Toreti VC, Sato HH, Pastore GM, Park YK. Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid Based Complement Alternat Med. 2013;2013:697390. doi:https://doi.org/10.1155/2013/697390
- Touzani S, Embaslat W, Imtara H, Kmail A, Kadan S, Zaid H, ElArabi I, Badiaa L, Saad B. In vitro evaluation of the potential use of propolis as a multitarget therapeutic product: physicochemical properties, chemical composition, and immunomodulatory, antibacterial, and anticancer properties. Biomed Res Int. 2019;2019:4836378. doi:https://doi.org/10.1155/2019/4836378
- Salatino A, Fernandes-Silva CC, Righi AA, Salatino MLF. Propolis research and the chemistry of plant products. Nat Prod Rep. 2011;28(5):925. doi:https://doi.org/10.1002/chin.201133268
- Siheri W, Alenezi S, Tusiimire J, Watson DG. The chemical and biological properties of propolis. In: Alvarez-Suarez J (Eds.), Bee products - chemical and biological properties. Cham: Springer; 2017.
- Silva-Carvalho R, Baltazar F, Almeida-Aguiar C. Propolis: a complex natural product with a plethora of biological activities that can be explored for drug development. Evidence-Based Complement Altern Med. 2015;2015:1–29. doi:https://doi.org/10.1155/2015/206439
- Bayram NE, Sorkun K, Salih B. Determination of major compounds in some Turkish propolis. Mellifera. 2013;13(26):3–9.
- Bayram S, Bayram NE, Gercek YC, Aydogan MN, Cevahir Oz G. Chemical analysis and antimicrobial effect of propolis from hakkari province of Turkey against some pathogenic microorganisms. Eur J Biol. 2017;76(2):74–8. doi:https://doi.org/10.5152/EurJBiol.2017.1713
- Ozdal T, Sari-Kaplan G, Mutlu-Altundag E, Boyacioglu D, Capanoglu E. Evaluation of Turkish propolis for its chemical composition, antioxidant capacity, anti-proliferative effect on several human breast cancer cell lines and proliferative effect on fibroblasts and mouse mesenchymal stem cell line. J Apic Res [Internet]. 2018;57(5):627–38. doi:https://doi.org/10.1080/00218839.2018.1494888
- Aliyazıcıoglu R, Sahin H, Erturk O, Ulusoy E, Kolayli S. Properties of phenolic composition and biological activity of propolis from Turkey. Int J Food Prop. 2013;16(2):277–87. doi:https://doi.org/10.1080/10942912.2010.551312
- Subramani K, Hosseinkhani H, Khraisat A, Hosseinkhani M, Pathak Y. Targeting nanoparticles as drug delivery systems for cancer treatment. CNANO. 2009;5(2):135–40. doi:https://doi.org/10.2174/157341309788185406
- Jawahar N, Meyyanathan S. Polymeric nanoparticles for drug delivery and targeting: a comprehensive review. Int J Health Allied Sci. 2012;1(4):217. doi:https://doi.org/10.4103/2278-344X.107832
- Okore VC, Attama AA, Ofokansi KC, Esimone CO, Onuigbo EB. Formulation and evaluation of niosomes. Indian J Pharm Sci. 2011;73(3):323–8.
- Kshitij B, Makeshwar SRW. Niosome: a novel drug delivery system. Asian J Pharm Res. 2013;3(1):15–19.
- Khan R, Irchhaiya R. Niosomes: a potential tool for novel drug delivery. J Pharm Investig. 2016;46(3):195–204. doi:https://doi.org/10.1007/s40005-016-0249-9
- Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52–79. doi:https://doi.org/10.1016/j.ejpb.2015.03.018
- Iqbal J, Abbasi BA, Mahmood T, Kanwal S, Ali B, Shah SA, Khalil AT. Plant-derived anticancer agents: a green anticancer approach. Asian Pac J Trop Biomed. 2017;7(12):1129–50. doi:https://doi.org/10.1016/j.apjtb.2017.10.016
- Singh S, Sharma B, Kanwar SS, Kumar A. Lead phytochemicals for anticancer drug development. Front Plant Sci. 2016;7:1667.
- Salehi B, Zucca P, Sharifi-Rad M, Pezzani R, Rajabi S, Setzer WN, Varoni EM, Iriti M, Kobarfard F, Sharifi-Rad J. Phytotherapeutics in cancer invasion and metastasis. Phytother Res. 2018;32(8):1425–49. doi:https://doi.org/10.1002/ptr.6087
- Žilius M, Ramanauskienė K, Juškaitė V, Briedis V. Formulation of propolis phenolic acids containing microemulsions and their biopharmaceutical characterization. Evid Based Complement Alternat Med. 2016;2016:8175265. doi:https://doi.org/10.1155/2016/8175265
- Butnariu MV, Giuchici CV. The use of some nanoemulsions based on aqueous propolis and lycopene extract in the skin’s protective mechanisms against UVA radiation. J Nanobiotechnol. 2011;9(1):3–9. doi:https://doi.org/10.1186/1477-3155-9-3
- Ambardekar RV, Mahadik KR, Paradkar AR, Harsulkar AM. Enhancement of hepatoprotective efficacy of propolis by fabrication of liposomes, as a platform nano-formulation for multi-component natural medicine. Curr Drug Deliv. 2012;9(5):477–86. doi:https://doi.org/10.2174/156720112802650653
- Patel J, Ketkar S, Patil S, Fearnley J, Mahadik KR, Paradkar AR. Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration. Integr Med Res. 2015;4(2):94–101. doi:https://doi.org/10.1016/j.imr.2014.10.004
- Arafa MG, Ghalwash D, El-Kersh DM, Elmazar MM. Propolis-based niosomes as oromuco-adhesive films: a randomized clinical trial of a therapeutic drug delivery platform for the treatment of oral recurrent aphthous ulcers. Sci Rep. 2018;8(1):1–14. doi:https://doi.org/10.1038/s41598-018-37157-7
- Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol [Internet]. 1965;13(1):238–52. doi:https://doi.org/10.1016/S0022-2836(65)80093-6
- Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari M. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57–17. doi:https://doi.org/10.3390/pharmaceutics10020057
- Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems - A review (Part 2). Trop J Pharm Res. 2013;12(2):265–73.
- Bilia AR, Piazzini V, Guccione C, Risaliti L, Asprea M, Capecchi G, Bergonzi MC. Improving on nature: the role of nanomedicine in the development of clinical natural drugs. Planta Med. 2017;83(5):366–81. doi:https://doi.org/10.1055/s-0043-102949
- Reed JC. Warner-Lambert/Parke Davis award lecture: mechanisms of apoptosis. Am J Pathol [Internet]. 2000;157(5):1415–30. doi:https://doi.org/10.1016/S0002-9440(10)64779-7
- Turan I, Demir S, Misir S, Kilinc K, Mentese A, Aliyazicioglu Y, Deger O. Cytotoxic effect of Turkish propolis on liver, colon, breast, cervix and prostate cancer cell lines. Trop J Pharm Res. 2015;14(5):777–82. doi:https://doi.org/10.4314/tjpr.v14i5.5